14 November 2020 04:34

Operation Warp Speed Andrew Cuomo New York

U.S. President Trump to deliver update on Operation Warp Speed at 4 p.m.

In the past nine months, my administration has initiated the single greatest mobilization in U.S. history — pioneering, developing, and manufacturing therapies and vaccines in record time. As a result of Operation Warp Speed, Pfizer announced on Monday that its China virus vaccine is more than 90 percent effective. As soon as April, the vaccine will be available to the entire general population, with the exception of places like New York state, where, for political reasons, the governor decided, they say — and, you know, I don't think it's good, politically; I think it's very bad from a health standpoint — but he wants to take his time with the vaccine. It's incredible, some of the antibody vaccines and others that have come out and have really helped people — 85 percent. The federal government has 22,000 beds immediately available for states and jurisdictions that need additional capacity, but we think that it's going to start going down, possibly very quickly.

So Operation Warp Speed's mission is to enable and accelerate the development of vaccines and therapeutics to help control the COVID-19 pandemic and save lives. On May 15th, almost six months ago to the day, we stated the goal of the operation, which was to have vaccines and therapeutics available and approved for use in the U.S. population by the end of the year 2020. I would like to take this opportunity to invite as many Americans as possible who would like to volunteer to participate in these clinical trials, as that's the only way we are able to achieve a demonstration of the safety and the efficacy of these vaccines. So the two vaccines that are completing their phase three trial are likely to be filing their files with the FDA for a potential emergency use authorization within the next few weeks. And finally, AstraZeneca, just in the last few days, has received a green light to start two large phase three trials with their monoclonal antibodies, supported by Operation Warp Speed, to prevent the acquisition of COVID-19 disease in very frail subjects or in very high-risk subjects, as a protective alternative to a vaccine.

And at every step has been and is being judged by independent expert bodies, whether it's when the FDA grants the green light to go into clinical trials, or whether when the Data Safety Monitoring Boards review the safety of the studies on an ongoing basis and sometimes put them on hold, as I'm sure you have witnessed with the AstraZeneca vaccine, for instance. I will now pass to my co-leader, General Perna, who will tell you more about the support that the operation has provided to manufacturing of the vaccine and also to their distribution. Let me start by emphasizing, for me, what is Operation Warp Speed about: It is about saving lives, and it is a herculean task that the President put us on many months ago. It is the partnerships we have formed with the pharmaceutical companies like Pfizer and Moderna; distribution companies like McKesson, FedEx, and UPS; and pharmacies like CVS and Walgreens that have agreed to do things differently, to think, "How can we get this to the American people in the most rapid and expedition- — expeditious way?" We will be successful because of this all-of-America approach, this collaboration, this effort that everybody is leading towards. The success that Operation Warp Speed has realized so far has been made possible only because of the bold vision you announced not even six months ago, right here in the Rose Garden.

The President said, "That's not acceptable." And thanks to the support he's provided, we're now on track to deliver a safe and effective vaccine to our most vulnerable this year. The President gave us the full financial support we needed, enabling us to invest more than $10 billion to de-risk vaccine companies' development efforts and manufacture product in advance. Our completely unprecedented partnership with the Defense Department has given us a comprehensive public-private plan for distribution and help each Operation Warp Speed vaccine maker secure what they needed for manufacturing, including Pfizer's ongoing production this week. Because the President has delivered the full funding we need, the best people on the planet, and real independence for this project, Operation Warp Speed is doing something that has never been done before in history. It was your vision that we could harness the ingenuity and the creativity of America's greatest pharmaceutical and research companies to speed, in record time, a vaccine that would save American lives.

That literally, pending FDA approval of the Pfizer vaccine and perhaps very soon another vaccine that will be submitted by Moderna and even other companies — that before the year is out, we'll be able to administer a vaccine to tens of millions of Americans, as you've said Mr. President, beginning with those most vulnerable, beginning with our seniors all across this country, beginning with our healthcare workers and first responders at the point of the need. And finally, Mr. President, as we see cases rising around the country, as we see hospitalizations rising around the country, I want to encourage the American people with the news that, as we have done from the very beginning, we're going to continue to move Heaven and Earth to make sure that your family has access to the level of healthcare that we'd want any one of our members of our family to have. So the good news today, through Operation Warp Speed, Mr. President, is help is on the way. But we want to encourage every American that we're going to continue to make sure that our healthcare system has the resources, the support, the equipment and supplies that they need. WASHINGTON (Reuters) - U.S. President Donald Trump on Friday will address the nation at 4 p.m. eastern time (2100 GMT) with an update on the so-called Operation Warp Speed program, according to a White House Statement.

In his first public comments since the week of the U.S. election, Trump will update on the U.S. government program that has struck deals with several drugmakers in an effort to help speed up the search for effective treatments for the ongoing global coronavirus pandemic. Watch live coverage as President Trump gives an update on Operation Warp Speed and his administration's coronavirus response. President Trump said on Friday that pharmaceutical giant Pfizer offered an "unfortunate misrepresentation" when the company distanced itself from Operation Warp Speed. "We were never part of the Warp Speed," Kathrin Jansen, senior vice president and head of vaccine research and development at Pfizer, told the New York Times on Sunday. Earlier this week, Pfizer and BioNTech said clinical data showed their COVID-19 vaccine candidate to be 90% effective and that they could file for emergency use authorization with U.S. Food and Drug Administration by the third week of November. In July, Pfizer struck a $1.95 billion deal with the federal government as part of Operation Warp Speed, in an effort to deliver 100 million doses of the vaccine. President Donald Trump to make remarks on Operation Warp Speed Public health experts worry that Trump's refusal to take aggressive action on the pandemic or to coordinate with the Biden team during the final two months of his presidency will only worsen the effects of the virus and hinder the nation's ability to swiftly distribute a vaccine next year. With more than 100,000 new confirmed U.S. cases reported daily for more than a week, Trump has been more focused on tracking the rollout of a vaccine, which won't be widely available for months. Although the president has consistently played down the pandemic, which has killed more than 240,000 Americans and infected more than 10 million people in the U.S., public health experts expressed worry about Trump's silence on the troubling spike in cases, as well as his refusal to begin coordination on virus issues with Biden's transition team. Some public health experts believe the task of persuading Americans to take the vaccine and widely distributing it could be as complicated as the vaccine's development.